These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
598 related items for PubMed ID: 11456360
1. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster. Lin WR, Lin HH, Lee SS, Tsai HC, Huang CK, Wann SR, Chen YS, Chiang SC, Yen MY, Liu YC. J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360 [Abstract] [Full Text] [Related]
2. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102 [Abstract] [Full Text] [Related]
4. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T. Ophthalmology; 2000 Aug; 107(8):1507-11. PubMed ID: 10919899 [Abstract] [Full Text] [Related]
5. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster. Kurokawa I, Murakawa K, Kumano K. Int J Clin Pract; 2007 Jul; 61(7):1223-9. PubMed ID: 17362479 [Abstract] [Full Text] [Related]
7. Valaciclovir: a review of its use in the management of herpes zoster. Ormrod D, Goa K. Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165 [Abstract] [Full Text] [Related]
8. Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model. Grant DM, Mauskopf JA, Bell L, Austin R. Pharmacotherapy; 1997 Jun; 17(2):333-41. PubMed ID: 9085325 [Abstract] [Full Text] [Related]
9. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Perry CM, Faulds D. Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821 [Abstract] [Full Text] [Related]
10. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older. Madkan VK, Arora A, Babb-Tarbox M, Aboutlabeti S, Tyring S. J Cutan Med Surg; 2007 Nov; 11(3):89-98. PubMed ID: 17511925 [Abstract] [Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT. Klein A, Miller KB, Sprague K, DesJardin JA, Snydman DR. Bone Marrow Transplant; 2011 Feb; 46(2):294-9. PubMed ID: 20421867 [Abstract] [Full Text] [Related]